Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh
International Journal of Biomedical Science · 15.03.2012 · 8 (1) · 36-39
DOI: 10.59566/ijbs.2012.8036 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedical Science, online erschienen am 15.03.2012. Verfasst von Sanjana Bhagat und 2 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref).
Abstract (Originalsprache)
The γG-158 (C-T) polymorphism plays important function in the disease severity of sickle cell anemia.The XmnI restriction site at -158 position of the γG-gene is associated with increased expression of the γG-globin gene and higher production of HbF. This study aims to determine the frequency of the different genotypes of the γG Xmn I polymorphism in sickle cell anemia and sickle cell trait patients in Chhattisgarh and its association with high HbFlevel. The Xmn1 polymorphic site was determined by PCR-RFLP procedure. XmnI polymorphism were studied in 100 sickle cell patients (SS), 50 sickle cell trait(AS) and 50 controls individuals (AA). The presence of XmnI (+/+) site in SS and AS patients associated with the increase of HbF (P
Zitieren
APA
Bhagat, S., Thakur, A. S., & Patra, P. K. (2012). Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh. International Journal of Biomedical Science, 8(1), 36-39. https://doi.org/10.59566/ijbs.2012.8036
Vancouver
Bhagat S, Thakur AS, Patra PK. Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh. International Journal of Biomedical Science. 2012;8(1):36-39. doi:10.59566/ijbs.2012.8036
BibTeX
@article{Bhagat2012,
author = {Bhagat, Sanjana and Thakur, Amar Singh and Patra, Pradeep Kumar},
title = {Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh},
journal = {International Journal of Biomedical Science},
year = {2012},
volume = {8},
number = {1},
pages = {36--39},
doi = {10.59566/ijbs.2012.8036}
}
EUVIMED